» Authors » Robin M Ireland

Robin M Ireland

Explore the profile of Robin M Ireland including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 416
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ireland R, Rees D
Blood . 2021 Sep; 138(12):1087. PMID: 34554218
No abstract available.
2.
Chiramel A, Meyerson N, McNally K, Broeckel R, Montoya V, Mendez-Solis O, et al.
Cell Rep . 2019 Jun; 27(11):3269-3283.e6. PMID: 31189110
Tripartite motif-containing protein 5α (TRIM5α) is a cellular antiviral restriction factor that prevents early events in retrovirus replication. The activity of TRIM5α is thought to be limited to retroviruses as...
3.
Bono E, McLornan D, Travaglino E, Gandhi S, Galli A, Khan A, et al.
Leukemia . 2019 Apr; 33(10):2495-2505. PMID: 30940907
Diagnostic criteria for hypoplastic myelodysplasic syndrome (h-MDS) have not been clearly established, making the differential diagnosis from other bone marrow failure syndromes (BMF) challenging. In this study, we aimed to...
4.
Roberts L, Wehrly T, Ireland R, Crane D, Scott D, Bosio C
J Immunol . 2018 Jul; 201(4):1186-1193. PMID: 29980611
The lung is a complex organ with anatomically distinct pools of T cells that play specific roles in combating infection. Our knowledge regarding the generation and/or maintenance of immunity by...
5.
Dowse R, Ireland R
Blood . 2017 Apr; 129(14):2038. PMID: 28385775
No abstract available.
6.
Ireland R
Blood . 2017 Feb; 129(6):803. PMID: 28183748
No abstract available.
7.
Ireland R
Blood . 2017 Jan; 128(8):1153. PMID: 28092902
No abstract available.
8.
Ireland R
Blood . 2016 Oct; 128(13):1777. PMID: 27688782
No abstract available.
9.
Ireland R
Blood . 2016 Jun; 127(5):662. PMID: 27257649
No abstract available.
10.
Potter V, Krishnamurthy P, Barber L, Lim Z, Kenyon M, Ireland R, et al.
Biol Blood Marrow Transplant . 2013 Nov; 20(1):111-7. PMID: 24216184
Allogeneic hematopoietic stem cell transplantation (HSCT) with reduced-intensity conditioning (RIC) offers a potential cure for patients with myelodysplastic syndrome (MDS) who are ineligible for standard-intensity regimens. Previously published data from...